CHGX — Chitogenx Cashflow Statement
0.000.00%
- CA$0.42m
- CA$4.60m
Annual cashflow statement for Chitogenx, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.49 | -3.77 | -4.92 | -6.23 | -1.55 |
Depreciation | |||||
Non-Cash Items | 0.782 | 1.45 | 1.26 | 1.52 | -1.21 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.003 | -0.752 | 0.368 | 1.46 | 1.71 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.59 | -2.98 | -3.22 | -3.2 | -1.01 |
Capital Expenditures | 0 | -0.003 | -0.033 | 0 | — |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | 0 | -0.003 | -0.033 | 0 | — |
Financing Cash Flow Items | -0.077 | -0.173 | 0.074 | 0.618 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 1.37 | 5.05 | 1.16 | 2.94 | 0.937 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.222 | 2.08 | -2.07 | -0.205 | -0.073 |